Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX
Klee Justin B. sold 100,000 Amylyx Pharmaceuticals, Inc. shares (Form 4)
Traded Nov 9, 2026 · Filed Nov 12, 2026
On Nov 9, 2026, Klee Justin B. (Director, Co-Chief Executive Officer) sold 100,000 Amylyx Pharmaceuticals, Inc. shares at an average US$29.84 for US$2.98M under a trading plan, leaving 3,513,056 shares. Filed Nov 12, 2026 (Form 4).
- Sold
- 100,000 shares
- Price
- US$29.84 average (US$29.39 to US$30.11)
- Value
- US$2.98M
- Holding after
- 3,513,056 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Co-Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | Common Stock | Sale | 37,483 | US$29.39 | 3,575,573 | Direct |
| Nov 9, 2026 | Common Stock | Sale | 62,517 | US$30.11 | 3,513,056 | Direct |
Source
Download original · View original at SEC
Related
- Amylyx Pharmaceuticals, Inc.
- Klee Justin B.
- Amylyx Pharmaceuticals, Inc. shareholders
- Form 4 · Klee Justin B. · Sep 14, 2026
- Form 4 · Klee Justin B. · Aug 20, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Nov 16, 2026
- Schedule 13G/A · Commodore Capital LP · Nov 16, 2026
- Form 4 · Frates James M · Nov 12, 2026
- Form 4 · Cohen Joshua B · Nov 12, 2026
- Form 4 · Milne George M Jr · Oct 7, 2026